Find a Doctor

Charles A. Stanley, MD

Emeritus Professor CE of Pediatrics, Perelman School of Medicine at the University of Pennsylvania

Abstracts

2012

Laje P, States LJ, Becker SA, Palladino AA, Stanley CA, Adzick NS. Accuracy of PET/CT scan in the diagnosis of the focal form of congenital hyperinsulinism [abstract]. British Association of Pediatric Surgeons; 2012.

States LJ, Becker S, Zhuang H, Adzick NS, Stanley CA. Detection of a focal lesion of congenital hyperinsulinism using 18[F]-DOPA PET/CT: lessons learned from 100 consecutive studies with histologic confirmation performed at the Children's Hospital of Philadelphia [abstract]. Monogenic Disorders of Insulin Secretion: Congenital Hyperinsulinism and Neonatal Diabetes Symposium,  The Children's Hospital of Philadelphia; 2012 Mar 15-16; Philadelphia, PA.

Stanescu DE, Hughes N, Kaplan B, Stanley CA, De Leon DD. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A [abstract]. Monogenic Disorders of Insulin Secretion: Congenital Hyperinsulinism and Neonatal Diabetes Symposium, The Children's Hospital of Philadelphia; 2012 Mar 15-16; Philadelphia, PA.

Snider KE, Ganguly A, Becker S, Boyajian L, Shyng SL, MacMullen C, et al.  Genotype-phenotype correlation in 440 children with congenital hyperinsulinism (HI) [abstract]. Monogenic Disorders of Insulin Secretion: Congenital Hyperinsulinism and Neonatal Diabetes Symposium, The Children's Hospital of Philadelphia; 2012 Mar 15-16; Philadelphia, PA. 

Pinney SE, Ganapathy K, Bradfield J, Givler S, Becker S, Hughes N, et al. Novel form of autosomal dominant hyperinsulinism maps to chromosome 10q21 [abstract]. Monogenic Disorders of Insulin Secretion: Congenital Hyperinsulinism and Neonatal Diabetes Symposium, The Children's Hospital of Philadelphia; 2012 Mar 15-16; Philadelphia, PA. 

Patel P, Li C, Givler S, Matschinsky F, Stanley CA, De Leon DD. Functional evaluation of islets from infants with KATP hyperinsulinism [abstract]. Monogenic Disorders of Insulin Secretion: Congenital Hyperinsulinism and Neonatal Diabetes Symposium, The Children's Hospital of Philadelphia; 2012 Mar 15-16; Philadelphia, PA. 

Lord K, Snider K, MacMullen C, Becker S, Ganguly A, Stanley CA. "Missing" mutations: post-zygotic mosaicism in congenital hyperinsulinism [abstract]. Monogenic Disorders of Insulin Secretion: Congenital Hyperinsulinism and Neonatal Diabetes Symposium, The Children's Hospital of Philadelphia; 2012 Mar 15-16; Philadelphia, PA. 

Li C, Patel P, Zhang T, Chen P, Givler S, Liu C, et al.  [U-13C]-glucose metabolism in islets from infants with KATP hyperinsulinism [abstract]. Monogenic Disorders of Insulin Secretion: Congenital Hyperinsulinism and Neonatal Diabetes Symposium, The Children's Hospital of Philadelphia; 2012 Mar 15-16; Philadelphia, PA.

Kalish JM, Snider K, Conlin KL, Bhatti T, Ganguly A, Stanley CA, et al. The spectrum of hyperinsulinism in mosaic Beckwith-Wiedemann syndrome: dissection of 11p15 paternal uniparental isodisomy [abstract]. Monogenic Disorders of Insulin Secretion: Congenital Hyperinsulinism and Neonatal Diabetes Symposium, The Children's Hospital of Philadelphia; 2012 Mar 15-16; Philadelphia, PA. 

Hughes N, Snider K, Carrie Coleman-Campbell C, Sayed S, Shen G, Boyajian L, et al. Mitochondrial uncoupling protein 2 (UCP2) mutations in CHOP hyperinsulinism (HI) patients [abstract]. Monogenic Disorders of Insulin Secretion: Congenital Hyperinsulinism and Neonatal Diabetes Symposium, The Children's Hospital of Philadelphia; 2012 Mar 15-16; Philadelphia, PA.

Conlin LK, Thiel BD, Mulchandani S, Kalish JM, Snider KE, Bhatti TR, et al. Detection and quantification of mosaic isodisomy in Beckwith-Wiedemann patients using SNP arrays {abstract]. Monogenic Disorders of Insulin Secretion: Congenital Hyperinsulinism and Neonatal Diabetes Symposium, The Children's Hospital of Philadelphia; 2012 Mar 15-16; Philadelphia, PA. 

2011

Stanescu D, Hughes N, Kaplan B, Stanley CA, DeLeon DD. Novel presentations of congenital hyperinsulinism due to mutations in hepatocyte nuclear factor 1 and 4 alpha [abstract].  Eastern Society of Pediatric Research; 2011 Mar 25-27; Philadelphia, PA.

Stanescu D, Hughes N, Kaplan B, Stanley CA, DeLeon DD. Novel presentations of congenital hyperinsulinism due to mutations in hepatocyte nuclear factor 1 and 4 alpha [abstract]. Pediatric Endocrine Society/PAS Meeting; 2011 Apr 30 - May 3; Denver, CO.

Lord K, Snider K, MacMullen C, Becker S, Ganguly A, Stanley CA. Missing mutations: post-zygotic mosaicisim in congenital hyperinsulinism [abstract]. CHOP Research Poster Day, 2011 Feb; Philadelphia, PA.

Lord K, Snider K, MacMullen C, Becker S, Ganguly A, Stanley CA. Missing mutations: post-zygotic mosaicisim in congenital hyperinsulinism [abstract]. Eastern Society for Pediatric Research Annual Meeting; 2011 Mar 25-27; Philadelphia, PA.

Lord K, Snider K, MacMullen C, Becker S, Ganguly A, Stanley CA. Missing mutations: post-zygotic mosaicisim in congenital hyperinsulinism [abstract]. Pediatric Academic Societies Annual Meeting; 2011 Apr 30 - May 3;  Denver, CO.

2010

Schiffman A, Becker S, Langson D, Stanley CA. Insulinomas in childhood: twenty year experience at the Children's Hospital of Philadelphia [abstract]. ENDO Society; 2010 Jun 19-22; San Diego, CA.

Books

Chapters

2012

Stanley CA, Matschinsky FM. Historical perspective on the genetic forms. In: Stanley CA, De Leon DD, editors. Monogenic hyperinsulinemic hypoglycemia diosrders. Basel (Switzerland): S. Karger AG; 2012. p. 1-6. (Frontiers in diabetes; vol. 21).

Sayed S, Matschinsky FM, Stanley CA. Hyperinsulinism due to activating mutations of glucokinase. In: Stanley CA, De Leon DD, editors. Monogenic hyperinsulinemic hypoglycemia diosrders. Basel (Switzerland): S. Karger AG; 2012. p. 146-57. (Frontiers in diabetes; vol. 21).

Li C, Matschinsky FM, Stanley CA.  Amino acid-stimulated insulin secretion: the role of the glutamine-glutamate-alpha-ketoglutarate axis. In: Stanley CA, De Leon DD, editors. Monogenic hyperinsulinemic hypoglycemia diosrders. Basel (Switzerland): S. Karger AG; 2012. p. 112-124. (Frontiers in diabetes; vol. 21).

Kelly A, Palladino A, Stanley CA. Congenital hyperinsulinism due to activating mutations of glutamate dehydrogenase: the hyperinsulinism/hyperammonemia syndrome. In: Stanley CA, De Leon DD, editors. Monogenic hyperinsulinemic hypoglycemia diosrders. Basel (Switzerland):S.  Karger AG; 2012. p. 100-11. (Frontiers in diabetes; vol. 21).

De Leon DD, Stanley CA:. Pathophysiology of diffuse ATP-sensitive potassium channel hyperinsulinism.  In: Stanley CA, De Leon DD, editors. Monogenic hyperinsulinemic hypoglycemia diosrders. Basel (Switzerland): S. Karger AG; 2012. p. 18-29. (Frontiers in diabetes; vol. 21).

2011

Stanley CA, Bennett MJ. Disorders of mitochondrial fatty acid beta-oxidation.In: Kliegman RM, Stanton BF, St. Geme III JW, Schor NF, Behrman RE, editors. Nelson textbook of pediatrics. 19th ed. Philadelphia: Elsevier Saunders; 2011. p. 456-62.

Hardy OT, Stanley CA. Hypoglycemia. In: Polin RA, Fox, WW, Abman SH, editors. Fetal and neonatal physiology: expert consult. Philadelphia: Elsevier Health Sciences Division; 2011. p. 568-75.

DeLeon D, Stanley CA. Hypoglycemia. In: Radovick S, MacGillivray MH, editors. Pediatric endocrinology: a practical clinical guide. 2nd ed. New York: Springer; 2011.

2008

Kelly A, Stanley CA. Hyperinsulinism. In: Sarafoglou K, editor. Pediatric endocrinology and inborn errors of metabolism. New York: McGraw Hill; 2008. p. 39-50.

2007

Stanley CA, Bennett MJ. Disorders of mitochondiralfFatty Acid oxidation. In: Kliegman RM, Behrman RE, Jenson HB, Stanton B, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia: Saunders Elsevier; 2007. p. 567-72.

2006

Stanley CA, Bennett MJ, Mayatepek E. Disorders of mitochondrial fatty acid oxidation and related metabolic pathways. In: Fernandes J, Saudubray JM, van den Berghe G, Walter JH, editors. Inborn metabolic diseases: diagnosis and treatment. 4th ed. Heidelberg (Germany): Springer Medizin Verlag; 2006. p. 175-90.

Hardy OT, Stanley CA. Hyperinsulinism of infancy: localization of focal forms. In: Charron M, editor. Practical pediatric PET imaging. New York: Springer; 2006. p. 479-84.

DeLeon DD, Stanley CA. When to screen for neonatal hypoglycemia. In: Wildschut H, Weiner CP, Peters TJ, editors. When to screen in obstetrics and gynecology. 2nd ed. Philadelphia: Saunders Elsevier; 2006. p. 483-90.

2005

Katz LL, Stanley CA. Disorders of glucose and other sugars. In: Spitzer AR, editor. Intensive care of the fetus & neonate. 2nd ed. Philadelphia: Elsevier, Inc.; 2005. p.1167-78.

2004

Stanley CA, Pallotto EK. Disorders of carbohydrate metabolism. In: Taeusch HW, Ballard RA, Gleason CA, editors. Avery's diseases of the newborn. 8th ed. Philadelphia: WB Saunders; 2004. p. 1410-22.

Stanley CA. Hypoglycemia. In: Kleigman RN, Greenbaum LA, Lye PS, editors. Practical strategies in pediatric diagnosis and therapy. 2nd ed.Philadelphia: Elsevier Saunders ; 2004. p. 1121-31. 

Kelly A, Changhong L, Stanley CA. Glucokinase/glutamate dehydrogenase interactions in the GDH form of congenital hyperinsulinism. In: Matschinsky FM, Magnuson MA, editors. Glucokinase and glycemic disease: from basics to novel therapeutics. Basel (Switzerland): S. Karger AG; 2004. p. 110-24. (Frontiers in Diabetes; vol. 16).

2003

Stanley CA, Caplin N. Pathophysiology of hypoglycemia. In: Polin R, Fox W, Abman S, editors. Fetal and neonatal physiology. 3rd ed. Philadelphia: WB Saunders; 2003. p. 494-99.

Stanley CA. Hypoglycemia. In: Radovick S, MacGillivray MH, editors. Pediatric endocrinology: a practical clinical guide. Totowa (NJ): Humana Press Inc.; 2003. p. 511-21.

2002

Thornton PA, Finegold DN, Stanley CA. Hypoglycemia in the infant and child. In: Sperling MA, editor. Pediatric endocrinology. Philadelphia: WB Saunders; 2002. p. 367-84.

Stanley, CA, Thornton, PS, Finegold, DN, Sperling, MA. Hypoglycemia in neonates and infants.  In: Sperling MA, editor. Pediatric endocrinology. Philadelphia: WB Saunders; 2002. p. 135-159.

2000

Stanley CA. Disorders of fatty acid oxidation. In: Fernandes J, Saudubray JM, van den Berghe G, editors. Inborn metabolic diseases. 3rd ed. Heidelberg: Springer-Verlag; 2000. p. 139-50, 2000.

Stanley CA. Hypoglycemia. In: Stockman JA, Lohr JA, editors. Essence of office pediatrics. Philadelphia: WB Saunders; 2000. p. 213.

Stanley CA. Lethargy and vomiting in a 14 month-old boy. In: Burg FD, Vaughan VC, Nelson KG, editors. Pediatrics: a problem-based review.  Philadelphia: W.B. Saunders Company; 2000. p. 232-35.

Stanley CA. Disorders of carbohydrate metabolism. In: Walker WA, Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB, editors. Pediatric gastrointestinal disease. Philadelphia: Decker; 2000.

1999

Stanley CA. The hyperinsulinism-hyperammonemia syndrome: gain-of-function mutations of glutamate dehydrogenase. In: O'Rahilly S, Dunger DB, editors. Genetic insights in pediatric endocrinology and metabolism. Bristol (UK): BioScientifica, Ltd.; 1999. p. 23-30.

Satin-Smith MS, Stanley CA. Hypoglycemia. In: Burg FD, Ingelfinger JR, Wald ER, Polin RA, editors. Gellis and Kagan's current pediatric therapy. 16th ed. Philadelphia: W.B. Saunders; 1999. p. 772-74.

1998

Stanley CA. Defects in metabolism of lipids. In:  Behrman RE, Kliegman RM, Jenson HB, editors. Nelson Textbook of Pediatrics. 16th ed. Philadelphia: Saunders; 1998.

Stanley CA. Defects in metabolism of lipids. In: Altschuler S, Ludwig S, editors. Endocrinology.  McGraw-Hill Publishing; 1998. Chapter 72, 90, 94, 96, 98 Pediatrics at a Glance, 1998.

Stanley CA. Neonatal carnitine metabolism. In: Cowett RM, editor. Principles of neonatal metabolism. 2nd ed. New York: Springer Verlaq; 1998. 

Nestorowicz A, Stanley CA, Landau H, Glaser B, Permutt MA. Familial hyperinsulinism in Ashkenazi Jews. In: Desnick RJ, editor. Advances in Jewish genetic diseases. New York: Oxford University Press;1998.

1995

Katz L, Stanley CA. Disorders of glucose and other sugars. In: Spitzer AR, editor. Intensive care of the fetus and neonate. Philadelphia: Mosby - Yearbook; 1996. p. 982-92.

Stanley CA. Carnitine/acylcarnitine translocase deficiency. In: Neurobase. Arbor Publishing Company; 1995.

Stanley CA: Carnitine palmitoyl transferase-1 (CPT-1) deficiency. In: Neurobase. Arbor Publishing Company; 1995.

Stanley CA: Medium-chain acyl-CoA dehydrogenase deficiency. In: Neurobase. Arbor Publishing Company; 1995.

1994

Stanley CA. Disorders of fatty acid oxidation. In: Fernandes J, Saudubray JM, Van Den Berghe T, editors. Inborn metabolic diseases: diagnosis and treatment. 2nd ed. Berlin (Germany): Springer-Verlag; 1994. p. 133-43.

Stanley CA. Defects in metabolism of lipids: disorders of mitochondrial fatty acid oxidation. In: Behrman RE, Kliegman RM, Arvin AM, Nelson WE, editors. Nelson's textbook of pediatrics. 15th ed. Philadelphia: WB Saunders; 1994. p. 360-63.

1992

Thornton PS, Berry GT, Stanley CA. Disorders of intermediary metabolism: organ system failure. In: Holbrook P, editor. Pediatric critical care; 1992. p. 725-40.

Stanley CA. Disorders of fatty acid oxidation. In:  Nelson's textbook of pediatrics. 14th ed. Philadelphia: W.B. Sauders; 1992. p. 336-38.

1991

Stanley CA. Disorders of carbohydrate metabolism. In: Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB, editors. Pediatric gastrointestinal disease: pathophysiology, diagnosis, management. Philadelphia: BC Decker; 1991. p. 936-43.

Stanley CA: Neonatal carnitine metabolism. In: Cowett RM, editor. Principles of neonatal metabolism. New York: Springer Verlag; 1991. p. 465-71.

1990

Stanley CA: Disorders of fatty acid oxidation. In: Fernandes J, Bremer E, Saudubray JM, editors. Inborn metabolic diseases: diagnosis and treatment. New York: Springer Verlag; 1990. p. 394-410.

Marx B, Stanley CA. Diabetes mellitus. In: Schwartz MW, Charney EB, Curry TA, Ludwig S, editors. Pediatric primary care. Chicago: Yearbook Medical Publishers; 1990. p. 423-29.

1987

Stanley CA. A 3-month old infant with a seizure. In: Clini-Pearls New York: Creative Medical Publications, Inc.; 1987. p. 1-4.

Marx B, Stanley CA. Diabetes. In: Schwartz MW, Ludwig S, Curry TA, Charney EB, editors. Principles and practice of clinical pediatrics. Chicago: Yearbook Medical Publishers; 1987. p. 348-54.

1985

Stanley CA. Intragastric feeding in glycogen storage disease and other disorders of fasting. In: Walker WA, Watkins JB, editors. Nutrition in pediatrics. Boston: Little, Brown & Co; 1985. p. 781-94.

1978

Stanley CA, Baker L. Hypoglycemia. In: Kaye R, Oski F, Barness L, editors. Core textbook of pediatrics. Philadelphia: J.B. Lippincott Co.; 1978; p. 280-305.

Baker L, Stanley CA. Diabetes in childhood. In:DeGroot l, Winegrad AI, editors. Endocrinology metabolic basis of clinical practice. New York: Grune and Stratton; 1978. p. 1057-60.

1977

Baker L, Stanley CA. Hyperinsulinism in infancy: a patho-physiologic approach to diagnosis and treatment. In: Chiumello G, editor. Rec Prog Pediatr Endocrinol. New York: Academic Press; 1977. p. 89-100.

Editorial and Academic Positions

Editorial Positions

Associate Editor, Diabetes

Academic and Institutional Committees

1985-present, GCRC Advisory Committee (Ex officio)
2000-present, DERC Executive Committee

Leadership

Memberships in Professional Organizations

Lawson Wilkins Pediatric Endocrine Society
American Association for the Advancement of Science
American Diabetes Association
American Pediatric Society
Association for Glycogen Storage Disease
Endocrine Society
John Morgan Society, University of Pennsylvania
Society for Inherited Metabolic Disorders
Society for Pediatric Research

Original Papers

2012

Calabria AC, Li C, Gallagher PR, Stanley CA, De León DD. GLP-1 Receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K+ channel. Diabetes. Epub 2012 Aug 1. Cited in PubMed; PMID 22855730. Read the abstract

Stanescu DE, Hughes N, Kaplan B, Stanley CA, De León DD. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A. J Clin Endocrinol Metab. Epub 2012 Jul 16. Cited in PubMed; PMID 22802087.  Read the abstract

Blomberg BA, Moghbel MC, Saboury B, Stanley CA, Alavi A. The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysis. Mol Imaging Biol. Epub 2012 Jul 3. Cited in PubMed; PMID 22752652. Read the abstract

Narayan SB, Master SR, Sireci AN, Bierl C, Stanley PE, Li C, et al. Short-chain 3-hydroxyacyl-coenzyme A dehydrogenase associates with a protein super-complex integrating multiple metabolic pathways. PLoS One. 2012;7(4):e35048. Epub 2012 Apr 9. Cited in PubMed; PMCID: PMC3322157. Read the article 

Laje P, Stanley CA, Palladino AA, Becker SA, Adzick NS. Pancreatic head resection and Roux-en-Y pancreaticojejunostomy for the treatment of the focal form of congenital hyperinsulinism. J Pediatr Surg. 2012 Jan;47(1):130-5. Cited in PubMed; PMID 22244405. Read the abstract 

Doliba NM, Qin W, Najafi H, Liu C, Buettger CW, Sotiris J, et al. Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics. Am J Physiol Endocrinol Metab. 2012 Jan 1;302(1):E87-E102. Epub 2011 Sep 27. Cited in PubMed; PMID 21952036. Read the abstract

2011

Li C, Li M, Chen P, Narayan S, Matschinsky FM, Bennett MJ, et al. Green tea polyphenols control dysregulated glutamate dehydrogenase in transgenic mice by hijacking the ADP activation site. J Biol Chem. 2011 Sep 30;286(39):34164-74. Epub 2011 Aug 3. Cited in PubMed; PMID 21813650. Read the abstract

Macmullen CM, Zhou Q, Snider KE, Tewson PH, Becker SA, Aziz AR, et al. Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1. Diabetes. 2011 Jun;60(6):1797-804. Epub 2011 May 2. Erratum in: Diabetes. 2011 Nov;60(11):3097. Cited in PubMed; PMID 21536946. Read the article

Palladino AA, Stanley CA. Nesidioblastosis no longer! It's all about genetics. J Clin Endocrinol Metab. 2011 Mar;96(3):617-9. No abstract available. Cited in PubMed; PMID 1378225. Read the article

Pingul MM, Hughes N, Wu A, Stanley CA, Gruppuso PA. Hepatocyte nuclear factor 4α gene mutation associated with familial neonatal hyperinsulinism and maturity-onset diabetes of the young. J Pediatr. 2011 May;158(5):852-4. Epub 2011 Feb 24. cited in PubMed; PMID 21353246. Read the abstract

Palladino AA, Stanley CA. A specialized team approach to diagnosis and medical versus surgical treatment of infants with congenital hyperinsulinism. in Pediatr Surg. 2011 Feb;20(1):32-7. Cited in PubMed; PMID 21186002. Read the abstract

2010

Li C, Chen P, Palladino A, Narayan S, Russell LK, Sayed S, et al. Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase. J Biol Chem. 2010 Oct 8;285(41):31806-18. Epub 2010 Jul 29. Cited in PubMed; PMID 20670938. Read the article

Laje P, Stanley CA, Adzick NS. Intussusception after pancreatic surgery in children: a case series. J Pediatr Surg. 2010 Jul;45(7):1496-9. Cited in PubMed; PMID 20638531. Read the abstract.

Dagli AI, Lee PJ, Correia CE, Rodriguez C, Bhattacharya K, Steinkrauss L, et al. Pregnancy in glycogen storage disease type Ib: gestational care and report of first successful deliveries. J Inherit Metab Dis. Epub 2010 Apr 13. Cited in PubMed; PMID 20386986.  Read the abstract.

Thornton PS, Stanley CA, De León D, Kelly A, Sperling MA, Wolfsdorf JI, et al. Research initiatives in neonatal hypoglycemia. J Pediatr. 2010 May;156(5):862-3; author reply 863. Epub 2010 Mar 20. Cited in PubMed; PMID 20304419. No abstract available. 

Posters and Presentations

2012

Abrams P, MacMullen C, De Leon D, Stanley CA. A case of late-onset hyperinsulinemic hypoglycemia worsened by exercise [poster presentation]. Pediatric Academic Society/Lawson Wilkins Pediatric Endocrine Society Meeting; 2010 May 1-4; Vancouver, BC.

Stanley CA. Diagnosis and management of hypoglycemia in infants and children [presentation]. George H. Lowrey Lecture in Pediatric Endocrinology Grand Rounds, University of Michigan; 2012 Apr; Ann Arbor, MI.

Stanley CA. Welcome, Introductions and symposium overview [presentation]. Congenital Hyperinsulinism and Neonatal Diabetes Symposium, The Children's Hospital of Philadelphia; 2012 Mar; Philadelphia, PA.

Stanley CA. KATP-channel hyperinsulinism variations [presentation]. Congenital Hyperinsulinism and Neonatal Diabetes Symposium, The Children's Hospital of Philadelphia; 2012 Mar; Philadelphia, PA.

Stanley CA. Glucokinase hyperinsulinism [presentation]. Congenital Hyperinsulinism and Neonatal Diabetes Symposium, The Children's Hospital of Philadelphia; 2012 Mar; Philadelphia, PA.

Stanley CA. Perinatal stress hyperinsulinism [presentation]. Monogenic disorder of insulin secretion: management of glucose in the preterm infant. NEO Conference; 2012 Feb; Orlando, FL.

2011

Stanley CA. Diagnosis and management of neonatal hypoglycemia(s) [presentation].  New York University Pediatric Grand Rounds; 2011 Feb; New York, NY.

Stanley CA. Hypoglycemia [presentation]. Neonatology Fellowship Physiology Lecture, The Children's Hospital of Philadelphia; 2011 Jan; Philadelphia, PA.

2010

Stanley CA. Congenital hyperinsulinism hypoglycemia: from bedside to bench [presentation]. Capital Medical University, Beijing Children's Hospital, Medical Continued Educational Course and Pediatric Endo Forum; 2010 May; Beijing, China

Stanley CA. GDH dysregulation in genetic forms of hyperinsulinemic hypoglycemia [presentation]. Symposium on Glutamate Dehydrogenase and Human Disease and the Sixth Aegean Meeting on Neurological Therapeutics; 2010 May; Heraklion, Crete, Greece.

Stanley CA. Genetic forms of hyperinsulinemic hypoglycemia in neonates and children [presentation]. Pediatric Grand Rounds, UMDNJ; 2010 Mar; Newark, NJ.

Stanley CA. Genetic disorders of insulin secretion in infants: over and under [presentation]. Grand Rounds Baylor College of Medicine; 2010 Feb; Houston, TX.

« Back to Previous Page
  • Print
  • Share

Contact Us